| Frontiers in Endocrinology | |
| GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH | |
| Rong-xuan Hua1  Qiu-Xuan Li1  Lei Gao2  Yue-Xin Guo3  Jing-Dong Xu4  Han Gao4  Bo-Ya Wang5  Hong-Wei Shang6  Xin Lu6  | |
| [1] Clinical Medicine of “5+3” Program, Xuanwu Hospital, Capital Medical University, Beijing, China;Department of Biomedical Informatics, School of Biomedical Engineering. Capital Medical University, Beijing, China;Department of Oral Medicine, Basic Medical College, Capital Medical University, Beijing, China;Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China;Eight Program of Clinical Medicine, Peking University Health Science Center, Beijing, China;Morphological Experiment Center, School of Basic Medical Sciences, Capital Medical University, Beijing, China; | |
| 关键词: GLP-1; Alzheimer’s disease; blood pressure; DPP-4; non-alcoholic steatohepatitis; signaling pathway; | |
| DOI : 10.3389/fendo.2021.721198 | |
| 来源: DOAJ | |
【 摘 要 】
GLP-1 is derived from intestinal L cells, which takes effect through binding to GLP-1R and is inactivated by the enzyme dipeptidyl peptidase-4 (DPP-4). Since its discovery, GLP-1 has emerged as an incretin hormone for its facilitation in insulin release and reduction of insulin resistance (IR). However, GLP-1 possesses broader pharmacological effects including anti-inflammation, neuro-protection, regulating blood pressure (BP), and reducing lipotoxicity. These effects are interconnected to the physiological and pathological processes of Alzheimer’s disease (AD), hypertension, and non-alcoholic steatohepatitis (NASH). Currently, the underlying mechanism of these effects is still not fully illustrated and a better understanding of them may help identify promising therapeutic targets of AD, hypertension, and NASH. Therefore, we focus on the biological characteristics of GLP-1, render an overview of the mechanism of GLP-1 effects in diseases, and investigate the potential of GLP-1 analogues for the treatment of related diseases in this review.
【 授权许可】
Unknown